IP Watchdog.com, the largest online intellectual property publication in the world and a leading source for news, information, analysis, and commentary in the patent and innovation industries published an article authored by partner Dan Shores entitled "mRNA Patent Wars Update: The Plot Thickens with Key Rulings Expected in 2025."
As previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and collaborators Pfizer+BioNTech seeking damages based on their respective sales of the Spikevax® and Comirnaty® COVID-19 vaccines. Key suits were filed by third party mRNA and lipid pioneers that, while not having any mRNA-based products on the market themselves, leveraged their patent portfolios claiming a share of the billions of dollars in sales the vaccines have generated. Direct competitors Moderna and Pfizer+BioNTech also clashed in patent litigation beginning in 2022, with cases initiated in the United States and later expanding abroad. Several of the original cases, filed over three years ago, have made their way through the courts relatively efficiently and are ripe for key rulings in the coming months. This is therefore an opportune time to check in and provide an update on the mRNA/LNP litigation landscape.
To read the full article, please visit the IPWatchdog.com website.
